Exact Mass: 771.6015824000001

PE(18:0/20:2(11Z,14Z))

C43H82NO8P (771.5777742)

PE(18:0/20:2(11Z,14Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/20:2(11Z,14Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:1(9Z)/20:1(11Z))

C43H82NO8P (771.5777742)

PE(18:1(9Z)/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(9Z)/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PC(15:0/20:2(11Z,14Z))

C43H82NO8P (771.5777742)

PC(15:0/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/20:2(11Z,14Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/20:2(11Z,14Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/20:2(11Z,14Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the eicosadienoic acid moiety is derived from fish oils and liver. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:0/P-18:1(11Z))

C44H86NO7P (771.6141576)

PC(18:0/P-18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/P-18:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(18:0/P-18:1(9Z))

C44H86NO7P (771.6141576)

PC(18:0/P-18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/P-18:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(18:1(11Z)/P-18:0)

C44H86NO7P (771.6141576)

PC(18:1(11Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/P-18:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(18:1(11Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/P-18:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:1(9Z)/P-18:0)

C44H86NO7P (771.6141576)

PC(18:1(9Z)/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/P-18:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(20:1(11Z)/P-16:0)

C44H86NO7P (771.6141576)

PC(20:1(11Z)/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:1(11Z)/P-16:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PC(20:2(11Z,14Z)/15:0)

C43H82NO8P (771.5777742)

PC(20:2(11Z,14Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:2(11Z,14Z)/15:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(20:2(11Z,14Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:2(11Z,14Z)/15:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(14:1(9Z)/24:1(15Z))

C43H82NO8P (771.5777742)

PE(14:1(9Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:1(9Z)/24:1(15Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(16:0/22:2(13Z,16Z))

C43H82NO8P (771.5777742)

PE(16:0/22:2(13Z,16Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/22:2(13Z,16Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the docosadienoic acid moiety is derived from animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(16:1(9Z)/22:1(13Z))

C43H82NO8P (771.5777742)

PE(16:1(9Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/22:1(13Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of erucic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:1(9Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/22:1(13Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of erucic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(18:1(11Z)/20:1(11Z))

C43H82NO8P (771.5777742)

PE(18:1(11Z)/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(11Z)/20:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:2(9Z,12Z)/20:0)

C43H82NO8P (771.5777742)

PE(18:2(9Z,12Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:2(9Z,12Z)/20:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:0/18:2(9Z,12Z))

C43H82NO8P (771.5777742)

PE(20:0/18:2(9Z,12Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/18:2(9Z,12Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:1(11Z)/18:1(11Z))

C43H82NO8P (771.5777742)

PE(20:1(11Z)/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/18:1(11Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(20:1(11Z)/18:1(9Z))

C43H82NO8P (771.5777742)

PE(20:1(11Z)/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/18:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of oleic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:1(11Z)/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/18:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of oleic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(20:2(11Z,14Z)/18:0)

C43H82NO8P (771.5777742)

PE(20:2(11Z,14Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:2(11Z,14Z)/18:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of stearic acid at the C-2 position. The eicosadienoic acid moiety is derived from fish oils and liver, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(22:1(13Z)/16:1(9Z))

C43H82NO8P (771.5777742)

PE(22:1(13Z)/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/16:1(9Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:1(13Z)/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/16:1(9Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(22:2(13Z,16Z)/16:0)

C43H82NO8P (771.5777742)

PE(22:2(13Z,16Z)/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/16:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:2(13Z,16Z)/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:2(13Z,16Z)/16:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(24:1(15Z)/14:1(9Z))

C43H82NO8P (771.5777742)

PE(24:1(15Z)/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/14:1(9Z)), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE-NMe2(18:1(9Z)/18:1(9Z))

C43H82NO8P (771.5777742)

PE-NMe2(18:1(9Z)/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(18:1(9Z)/18:1(9Z)), in particular, consists of two 9Z-octadecenoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(P-16:0/20:1(11Z))

C44H86NO7P (771.6141576)

PC(P-16:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/20:1(11Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-16:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/20:1(11Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of eicosenoic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(P-18:0/18:1(11Z))

C44H86NO7P (771.6141576)

PC(P-18:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/18:1(11Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of vaccenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(P-18:0/18:1(9Z))

C44H86NO7P (771.6141576)

PC(P-18:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/18:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of oleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/18:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of oleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(P-18:1(11Z)/18:0)

C44H86NO7P (771.6141576)

PC(P-18:1(11Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/18:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(11Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(11Z)/18:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(P-18:1(9Z)/18:0)

C44H86NO7P (771.6141576)

PC(P-18:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/18:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:1(9Z)/18:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(O-18:0/18:2(9Z,12Z))

C44H86NO7P (771.6141576)

PC(O-18:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:0/18:2(9Z,12Z)), in particular, consists of one chain of Stearyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Stearyl alcohol moiety is derived from beef fat, fish oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:0/18:2(9Z,12Z)), in particular, consists of one chain of Stearyl alcohol at the C-1 position and one chain of linoleic acid at the C-2 position. The Stearyl alcohol moiety is derived from beef fat, fish oil, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(O-18:1(9Z)/18:1(11Z))

C44H86NO7P (771.6141576)

PC(O-18:1(9Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(9Z)/18:1(11Z)), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of vaccenic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:1(9Z)/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/18:1(11Z)), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of vaccenic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(15:0/22:2(13Z,16Z))

C43H82NO8P (771.5777742)

PE-NMe(15:0/22:2(13Z,16Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/22:2(13Z,16Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(22:2(13Z,16Z)/15:0)

C43H82NO8P (771.5777742)

PE-NMe(22:2(13Z,16Z)/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:2(13Z,16Z)/15:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(16:1(9Z)/20:1(11Z))

C43H82NO8P (771.5777742)

PE-NMe2(16:1(9Z)/20:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(16:1(9Z)/20:1(11Z)), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(18:1(9Z)/18:1(11Z))

C43H82NO8P (771.5777742)

PE-NMe2(18:1(9Z)/18:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(18:1(9Z)/18:1(11Z)), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(18:1(11Z)/18:1(9Z))

C43H82NO8P (771.5777742)

PE-NMe2(18:1(11Z)/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(18:1(11Z)/18:1(9Z)), in particular, consists of one 11Z-octadecenoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(18:1(11Z)/18:1(11Z))

C43H82NO8P (771.5777742)

PE-NMe2(18:1(11Z)/18:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(18:1(11Z)/18:1(11Z)), in particular, consists of two 11Z-octadecenoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(14:0/22:2(13Z,16Z))

C43H82NO8P (771.5777742)

PE-NMe2(14:0/22:2(13Z,16Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(14:0/22:2(13Z,16Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(14:1(9Z)/22:1(13Z))

C43H82NO8P (771.5777742)

PE-NMe2(14:1(9Z)/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(14:1(9Z)/22:1(13Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(16:0/20:2(11Z,14Z))

C43H82NO8P (771.5777742)

PE-NMe2(16:0/20:2(11Z,14Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:0/20:2(11Z,14Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of eicosadienoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:0/18:2(9Z,12Z))

C43H82NO8P (771.5777742)

PE-NMe2(18:0/18:2(9Z,12Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/18:2(9Z,12Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of linoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:2(9Z,12Z)/18:0)

C43H82NO8P (771.5777742)

PE-NMe2(18:2(9Z,12Z)/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:2(9Z,12Z)/18:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:1(11Z)/16:1(9Z))

C43H82NO8P (771.5777742)

PE-NMe2(20:1(11Z)/16:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:1(11Z)/16:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(20:2(11Z,14Z)/16:0)

C43H82NO8P (771.5777742)

PE-NMe2(20:2(11Z,14Z)/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:2(11Z,14Z)/16:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:1(13Z)/14:1(9Z))

C43H82NO8P (771.5777742)

PE-NMe2(22:1(13Z)/14:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:1(13Z)/14:1(9Z)), in particular, consists of one chain of erucic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(22:2(13Z,16Z)/14:0)

C43H82NO8P (771.5777742)

PE-NMe2(22:2(13Z,16Z)/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(22:2(13Z,16Z)/14:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PC(18:2(9Z,12Z)/17:0)

C43H82NO8P (771.5777742)

Spinacetin 3-O-(2'-feruloylglucosyl)(1->6)-[apiosyl(1->2)]-glucoside

C43H82NO8P (771.5777742)

Phosphatidylcholine 17:0-18:2

C43H82NO8P (771.5777742)

Phosphatidylcholine alkyl 18:0-18:2

C44H86NO7P (771.6141576)

Phosphatidylethanolamine 18:1-20:1

C43H82NO8P (771.5777742)

Phosphatidylethanolamine 20:0-18:2

C43H82NO8P (771.5777742)

Phosphatidylcholine 17:1-18:1

C43H82NO8P (771.5777742)

Phosphatidylcholine alkenyl 18:0-18:1

C44H86NO7P (771.6141576)

Phosphatidylcholine alkyl 16:1-20:1

C44H86NO7P (771.6141576)

Phosphatidylethanolamine 18:0-20:2

C43H82NO8P (771.5777742)

PC 35:2

C43H82NO8P (771.5777742)

Found in mouse small intestine; TwoDicalId=471; MgfFile=160907_Small_Intestine_DHA_Neg_14; MgfId=1290

termitomycesphin B

C43H81NO10 (771.5860166)

termitomycesphin D

C43H81NO10 (771.5860166)

C18(Plasm)-18:1 PC

C44H86NO7P (771.6141576)

PE 38:2

C43H82NO8P (771.5777742)

Found in mouse brain; TwoDicalId=277; MgfFile=160720_brain_AA_19_Neg; MgfId=1636 Found in mouse spleen; TwoDicalId=1513; MgfFile=160729_spleen_DHA_14_Neg; MgfId=1425

GlcCer(d14:1(4E)/24:0(2OH))

C44H85NO9 (771.6224)

GlcCer(d16:1(4E)/22:0(2OH))

C44H85NO9 (771.6224)

PC(16:0/19:2)[U]

C43H82NO8P (771.5777742)

PC(17:0/18:2)[U]

C43H82NO8P (771.5777742)

PC(17:1/18:1)[U]

C43H82NO8P (771.5777742)

PE(20:2/18:0)[S]

C43H82NO8P (771.5777742)

PE(20:2/18:0)[U]

C43H82NO8P (771.5777742)

PE(20:2/18:0)

C43H82NO8P (771.5777742)

PE(18:0/20:2)

C43H82NO8P (771.5777742)

PE(20:0/18:2)

C43H82NO8P (771.5777742)

PE(18:1/20:1)

C43H82NO8P (771.5777742)

PE(18:1/20:1)[U]

C43H82NO8P (771.5777742)

PE(18:0/20:2)[U]

C43H82NO8P (771.5777742)

PE-NMe2(18:1/18:1)[U]

C43H82NO8P (771.5777742)

PE-NMe2(18:1/18:1)

C43H82NO8P (771.5777742)

PC(P-18:0/18:1)

C44H86NO7P (771.6141576)

PC(18:2/O-18:0)[U]

C44H86NO7P (771.6141576)

Lecithin

C43H82NO8P (771.5777742)

Lecithin

C44H86NO7P (771.6141576)

PE(38:2)

C43H82NO8P (771.5777742)

PC(13:0/22:2(13Z,16Z))

C43H82NO8P (771.5777742)

PC(15:1(9Z)/20:1(11Z))

C43H82NO8P (771.5777742)

PC(16:1(9Z)/19:1(9Z))

C43H82NO8P (771.5777742)

PC(17:0/18:2)

C43H82NO8P (771.5777742)

PC(17:1(9Z)/18:1(9Z))

C43H82NO8P (771.5777742)

PC(17:2(9Z,12Z)/18:0)

C43H82NO8P (771.5777742)

PC(18:0/17:2(9Z,12Z))

C43H82NO8P (771.5777742)

PC(18:1(9Z)/17:1(9Z))

C43H82NO8P (771.5777742)

PC(18:2(9Z,12Z)/17:0)

C43H82NO8P (771.5777742)

PC(19:1(9Z)/16:1(9Z))

C43H82NO8P (771.5777742)

PC(20:1(11Z)/15:1(9Z))

C43H82NO8P (771.5777742)

PC(22:2(13Z,16Z)/13:0)

C43H82NO8P (771.5777742)

PC(O-16:0/20:2(11Z,14Z))

C44H86NO7P (771.6141576)

PC(O-18:0/18:2(9Z,12Z))

C44H86NO7P (771.6141576)

PC(P-20:0/16:1(9Z))

C44H86NO7P (771.6141576)

PE(16:1(9Z)/22:1(11Z))

C43H82NO8P (771.5777742)

PE(17:2(9Z,12Z)/21:0)

C43H82NO8P (771.5777742)

PE(P-20:0/19:1(9Z))

C44H86NO7P (771.6141576)

PC O-36:2

C44H86NO7P (771.6141576)

PE O-39:2

C44H86NO7P (771.6141576)

HexCer 38:1;O3

C44H85NO9 (771.6224)

N-(2-hydroxyhenicosanoyl)-1-O-beta-D-glucosyl-15-methylhexadecasphing-4-enine

C44H85NO9 (771.6224)

2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O7P+ (771.6015824000001)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoylamino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O7P+ (771.6015824000001)

2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]amino]icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C43H84N2O7P+ (771.6015824000001)

[3-[(1Z,9Z)-octadeca-1,9-dienoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

HexCer 22:1;2O/16:0;O

C44H85NO9 (771.6224)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-henicos-11-enoate

C44H86NO7P (771.6141576)

NAGly 26:5/22:5

C50H77NO5 (771.5801432)

NAGly 26:7/22:3

C50H77NO5 (771.5801432)

NAGly 26:6/22:4

C50H77NO5 (771.5801432)

NAGly 22:6/26:4

C50H77NO5 (771.5801432)

NAGly 24:6/24:4

C50H77NO5 (771.5801432)

HexCer 18:1;2O/20:0;O

C44H85NO9 (771.6224)

HexCer 16:0;2O/22:1;O

C44H85NO9 (771.6224)

HexCer 20:0;2O/18:1;O

C44H85NO9 (771.6224)

HexCer 16:1;2O/22:0;O

C44H85NO9 (771.6224)

HexCer 17:0;2O/21:1;O

C44H85NO9 (771.6224)

HexCer 22:0;2O/16:1;O

C44H85NO9 (771.6224)

HexCer 19:1;2O/19:0;O

C44H85NO9 (771.6224)

HexCer 20:1;2O/18:0;O

C44H85NO9 (771.6224)

[2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

HexCer 17:1;2O/21:0;O

C44H85NO9 (771.6224)

HexCer 21:1;2O/17:0;O

C44H85NO9 (771.6224)

HexCer 21:0;2O/17:1;O

C44H85NO9 (771.6224)

HexCer 19:0;2O/19:1;O

C44H85NO9 (771.6224)

HexCer 18:0;2O/20:1;O

C44H85NO9 (771.6224)

HexCer 9:0;3O/28:2;(2OH)

C43H81NO10 (771.5860166)

HexCer 13:1;3O/24:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 12:1;3O/25:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 13:0;3O/24:2;(2OH)

C43H81NO10 (771.5860166)

HexCer 11:0;3O/26:2;(2OH)

C43H81NO10 (771.5860166)

[3-[(17Z,20Z)-octacosa-17,20-dienoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-hexacos-15-enoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] undecanoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] nonadecanoate

C44H86NO7P (771.6141576)

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]tricosa-4,8-diene-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-icos-11-enoate

C44H86NO7P (771.6141576)

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]tricos-4-ene-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] (Z)-octadec-9-enoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] tridecanoate

C44H86NO7P (771.6141576)

(4E,8E,12E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]tricosa-4,8,12-triene-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C44H86NO7P (771.6141576)

(4E,8E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyhenicosa-4,8-diene-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C44H86NO7P (771.6141576)

(4E,8E,12E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyhenicosa-4,8,12-triene-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] docosanoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] octadecanoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C44H86NO7P (771.6141576)

(4E,8E,12E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

C47H81NO5S (771.5835136)

(E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxypentacos-4-ene-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] heptadecanoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C44H86NO7P (771.6141576)

(4E,8E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxypentacosa-4,8-diene-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] pentadecanoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C44H86NO7P (771.6141576)

(E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyhenicos-4-ene-1-sulfonic acid

C47H81NO5S (771.5835136)

2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxyhenicosane-1-sulfonic acid

C47H81NO5S (771.5835136)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-docos-13-enoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] icosanoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tetracos-13-enoate

C44H86NO7P (771.6141576)

[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(Z)-henicos-11-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-icosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-dodecanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-heptadecanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-icos-11-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(Z)-docos-13-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-dodecoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-decoxy-2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-hexadecanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-heptadecoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-decanoyloxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

2-[4-[10,13-dimethyl-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]oxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C50H77NO5 (771.5801432)

Cer 14:0;2O/16:5;(3OH)(FA 20:6)

C50H77NO5 (771.5801432)

Cer 14:0;2O/20:6;(3OH)(FA 16:5)

C50H77NO5 (771.5801432)

Lpc 36:2-SN1

C44H86NO7P (771.6141576)

4-[3-heptadecanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(Z)-nonadec-9-enoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-nonadecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(Z)-henicos-11-enoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

HexCer 21:1;3O/16:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 17:2;3O/20:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 24:1;3O/13:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 14:2;3O/23:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 20:2;3O/17:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 22:2;3O/15:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 16:2;3O/21:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 22:1;3O/15:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 17:1;3O/20:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 15:1;3O/22:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 21:0;3O/16:2;(2OH)

C43H81NO10 (771.5860166)

HexCer 24:2;3O/13:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 25:1;3O/12:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 17:0;3O/20:2;(2OH)

C43H81NO10 (771.5860166)

HexCer 23:1;3O/14:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 19:1;3O/18:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 16:1;3O/21:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 15:2;3O/22:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 25:2;3O/12:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 19:2;3O/18:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 14:1;3O/23:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 15:0;3O/22:2;(2OH)

C43H81NO10 (771.5860166)

HexCer 21:2;3O/16:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 23:2;3O/14:0;(2OH)

C43H81NO10 (771.5860166)

HexCer 19:0;3O/18:2;(2OH)

C43H81NO10 (771.5860166)

HexCer 18:1;3O/19:1;(2OH)

C43H81NO10 (771.5860166)

HexCer 18:2;3O/19:0;(2OH)

C43H81NO10 (771.5860166)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] henicosanoate

C44H86NO7P (771.6141576)

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C44H86NO7P (771.6141576)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] tricosanoate

C44H86NO7P (771.6141576)

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(Z)-octadec-9-enoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-hexadecoxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[2-[(4Z,7Z)-octadeca-4,7-dienoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[3-[(Z)-hexadec-4-enoxy]-2-[(Z)-icos-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-[(E)-icos-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[3-[(E)-tetradec-9-enoyl]oxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-heptadecanoyloxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(E)-henicos-9-enoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(E)-heptadec-7-enoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(E)-dodec-5-enoyl]oxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-octadec-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[2-[(E)-dodec-5-enoyl]oxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-hexadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(E)-henicos-9-enoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(E)-heptadec-7-enoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-octadec-1-enoxy]-2-octadec-17-enoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[3-[(E)-nonadec-9-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[2-[(E)-nonadec-9-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-octadec-4-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[3-henicosanoyloxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-nonadecanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-tetradecanoyloxy-2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-tetradecanoyloxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-octadec-6-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-henicosanoyloxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-hexadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-2-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-heptadecanoyloxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-[(E)-icos-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-dodecanoyloxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

[(2R)-3-[(E)-octadec-1-enoxy]-2-[(E)-octadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C44H86NO7P (771.6141576)

4-[2-[(E)-tetradec-9-enoyl]oxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-dodecanoyloxy-2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-nonadecanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C47H81NO7 (771.6012716)

2-[[(E)-3,4-dihydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]octadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O7P+ (771.6015824000001)

2-[[(8E,12E)-3,4-dihydroxy-2-[[(Z)-icos-11-enoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O7P+ (771.6015824000001)

2-[[(8E,12E,16E)-3,4-dihydroxy-2-(icosanoylamino)octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O7P+ (771.6015824000001)

2-[[3,4-dihydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C43H84N2O7P+ (771.6015824000001)

1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-(1Z,9Z-octadecadienyl)-2-octadecanoyl-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-(1Z-hexadecenyl)-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-(1Z-octadecenyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-(1Z,11Z-octadecadienyl)-2-octadecanoyl-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

PC(O-18:1(9Z)/18:1(11Z))

C44H86NO7P (771.6141576)

1-stearoyl-2-(1-enyl-oleoyl)-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-oleoyl-2-(1-enyl-stearoyl)-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-stearoyl-2-(1-enyl-vaccenoyl)-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-vaccenoyl-2-(1-enyl-stearoyl)-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-Eicosenoyl-2-(1-enyl-palmitoyl)-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

1-(1Z-eicosenyl)-2-(9Z-hexadecenoyl)-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

phosphatidylcholine (P-18:0/18:1)

C44H86NO7P (771.6141576)

A phosphatidylcholine P-36:1 in which the 1-alk-1-enyl group contains 18 carbons and no additional double bonds while the 2-acyl group contains 18 carbons and 1 double bond.

phosphatidylcholine O-36:2

C44H86NO7P (771.6141576)

A glycerophosphocholine that is an alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 36 carbons and 2 double bonds.

1-hexadecyl-2-[(11Z,14Z)-eicosadienoyl]-sn-glycero-3-phosphocholine

C44H86NO7P (771.6141576)

A phosphatidylcholine O-36:2 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and (11Z,14Z)-eicosadienoyl respectively.

MePC(35:2)

C44H86NO7P (771.6141576)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(38:1)

C44H85NO9 (771.6224)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 33:1;O2

C43H81NO10 (771.5860166)

DGCC 34:0;O

C44H85NO9 (771.6224)

DGTS 34:0;O2

C44H85NO9 (771.6224)

DGTS 37:5

C47H81NO7 (771.6012716)

PC O-14:0/22:2

C44H86NO7P (771.6141576)

PC O-14:1/22:1

C44H86NO7P (771.6141576)

PC O-16:0/20:2

C44H86NO7P (771.6141576)

PC O-16:1/20:1

C44H86NO7P (771.6141576)

PC O-16:2/20:0

C44H86NO7P (771.6141576)

PC O-17:0/19:2

C44H86NO7P (771.6141576)

PC O-17:1/19:1

C44H86NO7P (771.6141576)

PC O-18:0/18:2

C44H86NO7P (771.6141576)

PC O-18:1/18:1

C44H86NO7P (771.6141576)

PC O-18:2/18:0

C44H86NO7P (771.6141576)

PC O-20:1/16:1

C44H86NO7P (771.6141576)

PC O-20:2/16:0

C44H86NO7P (771.6141576)

PC O-22:1/14:1

C44H86NO7P (771.6141576)

PC O-22:2/14:0

C44H86NO7P (771.6141576)

PC P-14:0/22:1

C44H86NO7P (771.6141576)

PC P-14:0/22:1 or PC O-14:1/22:1

C44H86NO7P (771.6141576)

PC P-16:0/20:1

C44H86NO7P (771.6141576)

PC P-16:0/20:1 or PC O-16:1/20:1

C44H86NO7P (771.6141576)

PC P-16:1/20:0

C44H86NO7P (771.6141576)

PC P-16:1/20:0 or PC O-16:2/20:0

C44H86NO7P (771.6141576)

PC P-17:0/19:1

C44H86NO7P (771.6141576)

PC P-17:0/19:1 or PC O-17:1/19:1

C44H86NO7P (771.6141576)

PC P-18:0/18:1

C44H86NO7P (771.6141576)

PC P-18:0/18:1 or PC O-18:1/18:1

C44H86NO7P (771.6141576)

PC P-18:1/18:0

C44H86NO7P (771.6141576)

PC P-18:1/18:0 or PC O-18:2/18:0

C44H86NO7P (771.6141576)

PC P-20:0/16:1

C44H86NO7P (771.6141576)

PC P-20:0/16:1 or PC O-20:1/16:1

C44H86NO7P (771.6141576)

PC P-20:1/16:0

C44H86NO7P (771.6141576)

PC P-20:1/16:0 or PC O-20:2/16:0

C44H86NO7P (771.6141576)

PC P-22:0/14:1

C44H86NO7P (771.6141576)

PC P-22:0/14:1 or PC O-22:1/14:1

C44H86NO7P (771.6141576)

PC P-22:1/14:0

C44H86NO7P (771.6141576)

PC P-22:1/14:0 or PC O-22:2/14:0

C44H86NO7P (771.6141576)

PC P-36:1

C44H86NO7P (771.6141576)

PC P-36:1 or PC O-36:2

C44H86NO7P (771.6141576)

PC P-18:0/18:1(9Z)

C44H86NO7P (771.6141576)

PE O-11:0/28:2

C44H86NO7P (771.6141576)

PE O-16:2/23:0

C44H86NO7P (771.6141576)

PE O-18:2/21:0

C44H86NO7P (771.6141576)

PE O-20:2/19:0

C44H86NO7P (771.6141576)

PE O-22:0/17:2

C44H86NO7P (771.6141576)

PE O-22:1/17:1

C44H86NO7P (771.6141576)

PE O-22:2/17:0

C44H86NO7P (771.6141576)

PE P-16:1/23:0

C44H86NO7P (771.6141576)

PE P-16:1/23:0 or PE O-16:2/23:0

C44H86NO7P (771.6141576)

PE P-18:1/21:0

C44H86NO7P (771.6141576)

PE P-18:1/21:0 or PE O-18:2/21:0

C44H86NO7P (771.6141576)

PE P-20:1/19:0

C44H86NO7P (771.6141576)

PE P-20:1/19:0 or PE O-20:2/19:0

C44H86NO7P (771.6141576)

PE P-22:0/17:1

C44H86NO7P (771.6141576)

PE P-22:0/17:1 or PE O-22:1/17:1

C44H86NO7P (771.6141576)

PE P-22:1/17:0

C44H86NO7P (771.6141576)

PE P-22:1/17:0 or PE O-22:2/17:0

C44H86NO7P (771.6141576)

PE P-39:1

C44H86NO7P (771.6141576)

PE P-39:1 or PE O-39:2

C44H86NO7P (771.6141576)

PC O-36:2 or PE O-39:2

C44H86NO7P (771.6141576)

CerP 18:2;O2/26:0;O

C44H86NO7P (771.6141576)

CerP 19:2;O2/25:0;O

C44H86NO7P (771.6141576)

CerP 20:1;O2/24:1;O

C44H86NO7P (771.6141576)

CerP 20:2;O2/24:0;O

C44H86NO7P (771.6141576)

CerP 21:2;O2/23:0;O

C44H86NO7P (771.6141576)

CerP 22:1;O2/22:1;O

C44H86NO7P (771.6141576)

CerP 22:2;O2/22:0;O

C44H86NO7P (771.6141576)

CerP 44:2;O2;O

C44H86NO7P (771.6141576)

GalCer 14:0;O2/24:1;O

C44H85NO9 (771.6224)

GalCer 14:0;O3/24:1

C44H85NO9 (771.6224)

GalCer 14:1;O2/24:0;O

C44H85NO9 (771.6224)

GalCer 15:1;O2/23:0;O

C44H85NO9 (771.6224)

GalCer 16:0;O2/22:1;O

C44H85NO9 (771.6224)

GalCer 16:0;O3/22:1

C44H85NO9 (771.6224)

GalCer 16:1;O2/22:0;O

C44H85NO9 (771.6224)

GalCer 17:1;O2/21:0;O

C44H85NO9 (771.6224)

GalCer 18:0;O2/20:1;O

C44H85NO9 (771.6224)

GalCer 18:0;O3/20:1

C44H85NO9 (771.6224)

GalCer 18:1;O2/20:0;O

C44H85NO9 (771.6224)

GalCer 19:1;O2/19:0;O

C44H85NO9 (771.6224)

GalCer 20:0;O2/18:1;O

C44H85NO9 (771.6224)

GalCer 20:0;O3/18:1

C44H85NO9 (771.6224)

GalCer 20:1;O2/18:0;O

C44H85NO9 (771.6224)

GalCer 21:0;O3/17:1

C44H85NO9 (771.6224)

GalCer 21:1;O2/17:0;O

C44H85NO9 (771.6224)

GalCer 22:0;O3/16:1

C44H85NO9 (771.6224)

GalCer 22:1;O2/16:0;O

C44H85NO9 (771.6224)

GalCer 38:1;O2;O

C44H85NO9 (771.6224)

GalCer 38:1;O3

C44H85NO9 (771.6224)

GlcCer 14:0;O2/24:1;O

C44H85NO9 (771.6224)

GlcCer 14:0;O3/24:1

C44H85NO9 (771.6224)

GlcCer 14:1;O2/24:0;O

C44H85NO9 (771.6224)

GlcCer 14:1;O2(4E)/24:0;O

C44H85NO9 (771.6224)

GlcCer 15:1;O2/23:0;O

C44H85NO9 (771.6224)

GlcCer 16:0;O2/22:1;O

C44H85NO9 (771.6224)

GlcCer 16:0;O3/22:1

C44H85NO9 (771.6224)

GlcCer 16:1;O2/22:0;O

C44H85NO9 (771.6224)

GlcCer 16:1;O2(4E)/22:0;O

C44H85NO9 (771.6224)

GlcCer 17:1;O2/21:0;O

C44H85NO9 (771.6224)

GlcCer 18:0;O2/20:1;O

C44H85NO9 (771.6224)

GlcCer 18:0;O3/20:1

C44H85NO9 (771.6224)

GlcCer 18:1;O2/20:0;O

C44H85NO9 (771.6224)

GlcCer 19:1;O2/19:0;O

C44H85NO9 (771.6224)

GlcCer 20:0;O2/18:1;O

C44H85NO9 (771.6224)

GlcCer 20:0;O3/18:1

C44H85NO9 (771.6224)

GlcCer 20:1;O2/18:0;O

C44H85NO9 (771.6224)

GlcCer 21:0;O3/17:1

C44H85NO9 (771.6224)

GlcCer 21:1;O2/17:0;O

C44H85NO9 (771.6224)

GlcCer 22:0;O3/16:1

C44H85NO9 (771.6224)

GlcCer 22:1;O2/16:0;O

C44H85NO9 (771.6224)

GlcCer 38:1;O2;O

C44H85NO9 (771.6224)

GlcCer 38:1;O3

C44H85NO9 (771.6224)

HexCer 14:0;O2/24:1;2OH

C44H85NO9 (771.6224)

HexCer 14:0;O2/24:1;3OH

C44H85NO9 (771.6224)

HexCer 14:0;O2/24:1;O

C44H85NO9 (771.6224)

HexCer 14:0;O3/24:1

C44H85NO9 (771.6224)

HexCer 14:1;O2/24:0;2OH

C44H85NO9 (771.6224)

HexCer 14:1;O2/24:0;3OH

C44H85NO9 (771.6224)

HexCer 14:1;O2/24:0;O

C44H85NO9 (771.6224)

HexCer 15:1;O2/23:0;2OH

C44H85NO9 (771.6224)

HexCer 15:1;O2/23:0;3OH

C44H85NO9 (771.6224)

HexCer 15:1;O2/23:0;O

C44H85NO9 (771.6224)

HexCer 16:0;O2/22:1;2OH

C44H85NO9 (771.6224)

HexCer 16:0;O2/22:1;3OH

C44H85NO9 (771.6224)

HexCer 16:0;O2/22:1;O

C44H85NO9 (771.6224)

HexCer 16:0;O3/22:1

C44H85NO9 (771.6224)

HexCer 16:1;O2/22:0;2OH

C44H85NO9 (771.6224)

HexCer 16:1;O2/22:0;3OH

C44H85NO9 (771.6224)

HexCer 16:1;O2/22:0;O

C44H85NO9 (771.6224)

HexCer 17:1;O2/21:0;2OH

C44H85NO9 (771.6224)

HexCer 17:1;O2/21:0;3OH

C44H85NO9 (771.6224)

HexCer 17:1;O2/21:0;O

C44H85NO9 (771.6224)

HexCer 18:0;O2/20:1;2OH

C44H85NO9 (771.6224)

HexCer 18:0;O2/20:1;3OH

C44H85NO9 (771.6224)

HexCer 18:0;O2/20:1;O

C44H85NO9 (771.6224)

HexCer 18:0;O3/20:1

C44H85NO9 (771.6224)

HexCer 18:1;O2/20:0;2OH

C44H85NO9 (771.6224)

HexCer 18:1;O2/20:0;3OH

C44H85NO9 (771.6224)

HexCer 18:1;O2/20:0;O

C44H85NO9 (771.6224)

HexCer 19:1;O2/19:0;2OH

C44H85NO9 (771.6224)

HexCer 19:1;O2/19:0;3OH

C44H85NO9 (771.6224)

HexCer 19:1;O2/19:0;O

C44H85NO9 (771.6224)

HexCer 20:0;O2/18:1;2OH

C44H85NO9 (771.6224)

HexCer 20:0;O2/18:1;3OH

C44H85NO9 (771.6224)

HexCer 20:0;O2/18:1;O

C44H85NO9 (771.6224)

HexCer 20:0;O3/18:1

C44H85NO9 (771.6224)

HexCer 20:1;O2/18:0;2OH

C44H85NO9 (771.6224)

HexCer 20:1;O2/18:0;3OH

C44H85NO9 (771.6224)

HexCer 20:1;O2/18:0;O

C44H85NO9 (771.6224)

HexCer 21:0;O3/17:1

C44H85NO9 (771.6224)

HexCer 21:1;O2/17:0;2OH

C44H85NO9 (771.6224)

HexCer 21:1;O2/17:0;3OH

C44H85NO9 (771.6224)

HexCer 21:1;O2/17:0;O

C44H85NO9 (771.6224)

HexCer 22:0;O3/16:1

C44H85NO9 (771.6224)

HexCer 22:1;O2/16:0;2OH

C44H85NO9 (771.6224)

HexCer 22:1;O2/16:0;3OH

C44H85NO9 (771.6224)

HexCer 22:1;O2/16:0;O

C44H85NO9 (771.6224)

HexCer 38:1;O2;O

C44H85NO9 (771.6224)

GLCAE 24:6

C50H77NO5 (771.5801432)

2-hydroxy-n-(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}docos-4-en-2-yl)hexadecanimidic acid

C44H85NO9 (771.6224)